Caboxen 20 (Cabozantinib) 20 mg Capsules
Caboxen 20 mg (Cabozantinib) is a potent multi-targeted tyrosine kinase inhibitor (TKI) that acts against VEGFR, MET, and AXL receptors to inhibit tumor growth and angiogenesis.
Manufacturer: Everest Pharmaceuticals. Each pack contains 90 capsules. It is designed to treat cancers that may be resistant to other therapies by blocking multiple pathways involved in cancer progression and metastasis.
Key Feature:
Known for its dual mechanism of action, targeting both the tumor cells directly and their blood supply, making it effective in advanced stages of kidney and liver cancer.
Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 18.03.2026
Similar products
What Customers Say
No reviews yet
Your review can be the first!